🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: MicardisPlus®

Found 11 matching trials

Evaluation of the Effect of Telmisartan on Blood Pressure Control of High Risk Patients

N/A

The study is designed to evaluate the effect of treatment with Micardis/Mic...

Status

Completed

Location

Boehringer Ingelheim Investigational Site 1

Start Date

2010-04

Trial ID

NCT01108809

Treatments Being Tested

Telmisartan or Telmisartan and Hydrochlorthiazide

Post Marketing Surveillance Study in Rehabilitation Clinics (Cardio, Nephro, Diabetes, Pulmo)

N/A

Study to obtain long-term data on effects, safety and tolerability in routi...

Status

Completed

Location

Multiple Locations

Start Date

2003-01

Trial ID

NCT02262611

Treatments Being Tested

Micardis®MicardisPlus®

Micardis® / MicardisPlus® Program for Therapy Optimization With Telmisartan in Cardiovascular Diseases (PROTEKT)

N/A

Study to evaluate efficacy and tolerability of Micardis®/MicardisPlus® unde...

Status

Completed

Location

Multiple Locations

Start Date

2003-09

Trial ID

NCT02262637

Treatments Being Tested

Micardis®MicardisPlus®

Relative Bioavailability of Telmisartan and HCTZ in Two Experimental Formulations Compared to the Standard Formulation Telmisartan and HCTZ in Healthy Female and Male Subjects

PHASE1

Study to assess the comparative pharmacokinetics of telmisartan/HCTZ in two...

Status

Completed

Location

Multiple Locations

Start Date

2003-04

Trial ID

NCT02262572

Treatments Being Tested

Telmisartan /HCTZ - compression tablet (DC)Telmisartan /HCTZ - dry granulation tablet (DG)Telmisartan /HCTZ - present commercial formulation

Post-marketing Surveillance Study With MicardisPlus® in Treatment of Morning Hypertension (Self-monitored by Patient)

N/A

The purpose of the study was to examine the effect of six- to eight-week tr...

Status

Completed

Location

Multiple Locations

Start Date

2006-04

Trial ID

NCT02243566

Treatments Being Tested

MicardisPlus®

Evaluation of the Effect of Telmisartan (Micardis® 80 mg/ MicardisPlus® 80/12.5 mg) on Blood Pressure and Cardiovascular Risk Factor Index in High Risk Hypertensive Patients

N/A

The study is designed to evaluate the effect of treatment with Micardis/Mic...

Status

Completed

Location

Boehringer Ingelheim Investigational Site 24

Start Date

2009-12

Trial ID

NCT00904371

A Study of a Hypertensive Population Under Treatment With Micardis® and Micardis Plus® to Control the Early Morning BP Rise (SURGE II)

N/A

The primary objective was to evaluate, through the use of Home blood pressu...

Status

Completed

Location

Multiple Locations

Start Date

2005-08

Trial ID

NCT02242396

Treatments Being Tested

Telmisartan Telmisartan hydrochlorothiazide

A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients

PHASE4

The primary objective of this study is to compare the effectiveness of telm...

Status

Completed

Location

Boehringer Ingelheim Investigational Site

Start Date

2003-09

Trial ID

NCT00240448

Treatments Being Tested

telmisartan 80 mg/hydrochlorothiazide 25 mg valsartan 160 mg/hydrochlorothiazide 25 mg placebo

Study to Evaluate the Effect of the Treatment With Micardis® or MicardisPlus® on Blood Pressure

N/A

The primary objective was to evaluate the effect of the treatment with Mica...

Status

Completed

Location

Multiple Locations

Start Date

2006-01

Trial ID

NCT02242864

Treatments Being Tested

Micardis®MicardisPlus®

Study to Evaluate the Effect of Micardis® / MicardisPlus® on Metabolic Parameters in Patients With Essential Hypertension and Diabetes Mellitus

N/A

The primary objective is to evaluate the effect of the treatment with Micar...

Status

Completed

Location

Multiple Locations

Start Date

2006-01

Trial ID

NCT02242825

Treatments Being Tested

Micardis®MicardisPlus®

Previous Next